Skip to content
2000
Volume 11, Issue 1
  • ISSN: 1570-1638
  • E-ISSN: 1875-6220

Abstract

Antibodies have emerged as powerful therapeutics effective for treating a number of human conditions and diseases. While early successes utilized small animals to generate therapeutic antibodies, human antibodies are now preferred in order to limit anti-antibody immune responses. Antibodies with human amino acid sequences can be generated in a number of ways, such as humanizing antibodies from other species or expressing human antibodies in transgenic animals. This review focuses on methods for obtaining antibodies directly from human B cells. These methods use both antigen exposed and non-exposed (“naive”) humans as B cell sources, and apply various technologies to isolate desired antibodies; including cell line generation, single cell isolation, display technologies, and B cell library generation.

Loading

Article metrics loading...

/content/journals/cddt/10.2174/1570163811666140121154649
2014-03-01
2025-12-08
Loading full text...

Full text loading...

/content/journals/cddt/10.2174/1570163811666140121154649
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test